Taken together, two aspects are noteworthy: First, the alterations of the intestinal microbiota that we observed in patients with AD are only partly found in patients with MCI (e.g. higher abundance of Bacteroidetes) and not present in the at-risk group of APOE4 carriers. Here, APOE is linked to Alzheimer disease.